Monte Rosa Therapeutics Initiates INDEnabling Studies for MRT8102 A Potential GameChanger in Inflammatory Disease Treatment
Monte Rosa Therapeutics has recently announced the commencement of IND enabling studies for MRT-8102, a groundbreaking NEK7-targeted molecular glue degrader ...
